Bluejay Diagnostics Inc.

BJDX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.01

+$0.10 (+10.75%)

Sep 22, 2026, 1:14 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+10.75%

(1D)

Rating

Updated: Aug 27, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $1.05M

1D Range

0.90 1.02

52W Range

0.80 16.68

Valuation (TTM)

PE -0.08

PB 0.10

EV/EBITDA 1.20

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -661.1%

SBC Adj. FCF Yield -661.1%

SBC Impact 0.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | -100.0%

Dil EPS 3Y | 5Y 48.0% | 9.3%

FCF 3Y | 5Y 16.2% | 7.1%

Returns

ROA -63.0%

ROE -125.0%

ROIC -77.5%

Financial Health

Net Cash

$9.53M

Current Ratio 4.64

Interest Coverage -19,027.83

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of...

Sector Healthcare

Industry Medical - Devices

Employees 6

IPO Date Nov 9, 2021

Website bluejaydx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.